Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celgene Corp (CELG US)
Watchlist
77
Analysis
Health Care
•
United States
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Abbvie Inc
•
11 Jun 2024 03:00
•
Issuer-paid
Abbvie Inc - Regenerative Healthcare - Stem Cells & ALS Thematic 10062024
Regenerative medicine remains an extremely exciting area of healthcare with vast investment potential. In spite of the usual setbacks in valuation...
ACF Equity Research
Follow
202 Views
Share
bearish
•
Microsoft Corp
•
29 Jul 2022 07:09
Microsoft: Growth Bulls Versus Value Bears
US Growth managers are relying on Microsoft to deliver an increasing proportion of the Growth within their portfolios. The cost of that growth is...
Steven Holden
Follow
355 Views
Share
bullish
•
Antengene
•
06 Nov 2020 07:40
Antengene: Gunning To Move Up in Line
This Insight provides an in-depth review of pre-revenue biotechnology Antegene that plans to list on the HKEX. We discuss the pipeline, market...
Kemp Dolliver, CFA
456 Views
Share
bullish
•
LY
•
29 Nov 2019 13:02
(Mostly) Asia M&A: November 2019 Roundup
For the month of November, 21 new deals were discussed on Smartkarma with an overall announced deal size of ~US$75bn, helped in large part by...
David Blennerhassett
Follow
592 Views
Share
bullish
•
Allergan Plc
•
31 Aug 2019 08:47
Allergan Plc Acquisition by AbbVie Inc. – A Botox Deal with Some Wrinkles
On June 25, 2019, Abbvie Inc (ABBV US) announced its acquisition of Botox-maker Allergan Plc (AGN US) in a $63 billion cash and stock deal in which...
John DeMasi
Follow
622 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x